New liposomal liver-specific contrast agent for CT: first human phase I clinical trial assessing efficacy and safety.

Academic radiology

Volumn 5 Suppl 1, Issue , 1998, Pages

  Leander, P ^a   Hoglund P ^a   Kloster, Y ^a   Borseth A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; IODIXANOL; IODOBENZOIC ACID DERIVATIVE; LIPOSOME;

ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER; MALE; PHASE 1 CLINICAL TRIAL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

CONTRAST MEDIA; FEMALE; HUMANS; LIPOSOMES; LIVER; MALE; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS;

MLCS; MLOWN;

EID: 0032039992     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1076-6332(98)80044-5     Document Type: Article

References (0)